BUZZ-ADMA Biologics slips after short‑seller Culper Research alleges inflated sales

ADMA Biologics, Inc. +1.53% Post

ADMA Biologics, Inc.

ADMA

10.65

10.74

+1.53%

+0.86% Post

** Shares of ADMA Biologics ADMA.O fall 7.7% to $12.55

** Culper Research says it is short on ADMA

** Culper accuses the company of inflating its sales figures by pushing excess inventory onto distributors

** Culper estimates that ADMA's revenues fell 3% in 2025, not the 20% growth the company reported for the year

** ADMA did not immediately respond to a Reuters request for comment

** Including session's moves, stock down 30.9% YTD


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.